Axa S.A.
AXAHF | OTC
$46.25
+$0.55 (+1.20%)
Oct 28, 2025, 1:44 PM ET · Market open
TTM Period Ending | Q2 2025 Jun 29, 2025 | Q4 2024 Dec 30, 2024 | Q2 2024 Jun 29, 2024 | Q4 2023 Dec 30, 2023 | Q2 2023 Jun 29, 2023 | Q4 2022 Dec 30, 2022 | Q2 2022 Jun 29, 2022 | Q4 2021 Dec 30, 2021 | Q2 2021 Jun 29, 2021 | Q4 2020 Dec 30, 2020 | Q2 2020 Jun 29, 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 91.23B | 89.82B | 90.56B | 87.15B | 85.23B | 86.85B | 105.08B | 122.84B | 122.19B | 113.6B | 111.9B |
Cost of Revenue | 64.11B | n/a | -64.03B | 144M | -13.66B | -13.73B | n/a | n/a | n/a | n/a | n/a |
Gross Profit | 27.12B | 89.82B | 154.59B | 87.01B | 98.9B | 100.58B | 105.08B | 122.84B | 122.19B | 113.6B | 111.9B |
Operating Income | 50.94B | 9.98B | 9.94B | 9.24B | 7.26B | 7.48B | 7.47B | 4.87B | 4B | 2.72B | 1.4B |
Interest Income | n/a | n/a | 282M | 609M | 657M | 590M | 369M | 231M | 244M | 439M | 317M |
Pretax Income | 9.68B | 9.98B | 9.46B | 8.89B | 6.69B | 6.58B | 8.81B | 9.05B | 7.41B | 4.47B | 4.3B |
Net Income | 7.79B | 7.89B | 7.28B | 7B | 4.86B | 4.88B | 6.96B | 7.1B | 5.55B | 2.99B | 2.75B |
Selling & General & Admin | n/a | n/a | n/a | n/a | 5.36B | 5.36B | 2.68B | 5.19B | 5.23B | 5.36B | 2.64B |
Research & Development | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Expenses | 42.25B | 42.25B | 41.01B | 41.01B | n/a | n/a | -12.97B | -24.06B | -22.85B | -23.43B | -23.93B |
Operating Expenses | 42.25B | 42.25B | 41.01B | 77.66B | 77.85B | 79.62B | 51.39B | 24.06B | 22.85B | 23.43B | 23.93B |
Interest Expense | 23M | 607M | 584M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 287M |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 40.29B | 79.85B | 80.56B | 77.66B | 77.85B | 79.62B | -18.32B | -112.49B | -113.73B | -107.05B | -105.03B |
Income Tax Expense | 2.39B | 2.46B | 1.91B | 1.51B | 1.47B | 1.38B | 1.6B | 1.69B | 1.72B | 1.54B | 1.59B |
Shares Outstanding (Basic) | 2.28B | 2.19B | 2.27B | 2.28B | 2.28B | 2.28B | 2.33B | 2.38B | 2.38B | 2.39B | 2.38B |
Shares Outstanding (Diluted) | 2.16B | 2.2B | 2.22B | 2.26B | 2.26B | 2.26B | 2.34B | 2.39B | 2.39B | 2.39B | 2.39B |
EPS (Basic) | 3.46 | 3.46 | 3.15 | 3.07 | 2.13 | 2.10 | 2.96 | 2.99 | 2.33 | 1.25 | 1.15 |
EPS (Diluted) | 3.45 | 3.50 | 3.22 | 3.11 | 2.16 | 2.11 | 2.95 | 2.97 | 2.32 | 1.25 | 1.15 |
EBITDA | 434M | n/a | -870M | -738M | -928M | -1.22B | -859M | -472M | -361M | -458.5M | 309.5M |
EBIT | -889M | 10.59B | 19.86B | 18.46B | 14.5B | 14.86B | 14.75B | 9.62B | 7.95B | 5.4B | 5.24B |
Depreciation & Amortization | 6.17B | n/a | -6.17B | -5.04B | -7.26B | -7.48B | -4.63B | 870M | 846M | 1.18B | 1.17B |
Add to Watchlist
Select watchlists to add or remove AXAHF